Editor’s note: In this article, David A. Strahle, M.D., candidly shares how and why he and his team became involved with the systematic development of an abbreviated protocol for screening breast magnetic resonance imaging (MRI) and what they learned after carefully evaluating the data. This...
Imaging
-
-
A U.S. Food and Drug Administration (FDA) review of the safety ramifications of gadolinium-based contrast agents for magnetic resonance imaging (MRI) has not identified adverse health affects from gadolinium retained in the brain. The FDA released a drug safety communication regarding all...
-
Philips announced the debut of its TrueVue, GlassVue and aRevealA.I. capabilities on the company’s Epiq 7 and 5 and Affiniti 70 and 50 ultrasound systems. The new visualization tools work together to enable photorealistic, transparent and 3-D visualization in one touch, delivering more...
-
The term mesothelioma was coined in 1909, just a few years after the introduction of medical X-ray imaging. The term was developed after thousands of autopsies, numerous discoveries and significant research linked asbestos to a deadly form of cancer.
-
David Wolinsky, M.D., director of nuclear cardiology at Cleveland Clinic Florida and past-president of the American Society of Nuclear Cardiology (ASNC), discusses advancements in nuclear imaging and some of the issues facing the subspecialty.
News | Mammography | June 23, 2017
June 23, 2017 — French radiology technology company Therapixel was recently named the winner of the Digital...
Feature | Lung Cancer | June 23, 2017
June 23, 2017 — The American Society for Radiation Oncology (ASTRO) recently issued a new clinical guideline for the...
News | Computed Tomography (CT) | June 22, 2017
June 22, 2017 — Riverain Technologies announced that it is now processing data from nearly 50...
News | Radiation Dose Management | June 21, 2017
June 21, 2017 — RadNet Inc. and Medic Vision Imaging Solutions Ltd. announced that RadNet has acquired an equity...
News | Business | June 21, 2017
June 21, 2017 — The Radiological Society of North America (RSNA) Research and Education (R&E) Foundation will...
News | Pediatric Imaging | June 21, 2017
June 21, 2017 — In an article published in the June 2017 issue of...
News | Digital Radiography (DR) | June 20, 2017
June 20, 2017 — Carestream Health will show the DRX-Revolution Nano Mobile...
Tc-99m MDP bone scan (left) is negative for osseous lesions. NaF/FDG PET/MRI (right and second slide) confirms absence of bone metastases, but shows liver metastases. Image courtesy of Stanford University.
News | PET-MRI | June 20, 2017
June 20, 2017 — Simultaneous injections of the radiopharmaceuticals fluorine-18 fluorodeoxyglucose (18F-FDG) and 18F...
WLE specimen from a patient with a grade 3, ER-/HER2-, no special type (NST) carcinoma. (A) Cerenkov image; (B) Grey-scale photographic image overlaid with Cerenkov signal. An increased signal from the tumor is visible (white arrows); mean radiance is 871 ± 131 photons/s/cm2/sr, mean TBR is 3.22. Both surgeons measured the posterior margin (outlined in blue) as 2 mm (small arrow); a cavity shaving would have been performed if the image had been available intraoperatively. The medial margin (outlined in green) measured >5 mm by both surgeons. Pathology ink prevented assessing the lateral margin; a phosphorescent signal is visible (open arrows). (C) Specimen radiography image. The absence of one surgical clip to mark the anterior margin, and the odd position of the superior margin clip (white arrow) prevented reliable margin assessment. (D) Combined histopathology image from two adjacent pathology slides on which the posterior margin (bottom of image) and part of the primary tumor are visible (open arrows). The distance from the posterior margin measured 3 mm microscopically (double arrow). The medial margin is > 5 mm (not present in image). Credit: A. D. Purushotham, M.D., King’s College London, UK
News | Nuclear Imaging | June 20, 2017
June 20, 2017 — Breast-conserving surgery (BCS) is the primary treatment for early-stage...
News | Image Guided Radiation Therapy (IGRT) | June 19, 2017
June 19, 2017 — The Henry Ford Cancer Institute is the first in Michigan – and first in the world – to offer...
News | Radiation Dose Management | June 19, 2017
June 19, 2017 — The tenth special edition Image Wisely Radiation Safety Case is now available to help radiologists,...
Technology | CT Angiography (CTA) | June 16, 2017
June 16, 2017 — The U.S. Food and Drug Administration (FDA) has expanded the indication for GE Healthcare’s ...
News | Magnetic Resonance Imaging (MRI) | June 16, 2017
The U.S. Food and Drug Administration (FDA) has cleared the Magnetom Vida 3 Tesla (3T)...
Stéphane Bordas, Professor in Computational Mechanics at the Faculty of Science, Technology and Communication of the University of Luxembourg, and his team have developed methods to train surgeons, help them rehearse for such complex operations and guide them during surgery. Image © Legato Team / University of Luxembourg.
News | Information Technology | June 16, 2017
Researchers from the University of Luxembourg, in cooperation with the University of Strasbourg, have developed a...
A 77-year-old male with recurrent lymph node and pulmonary metastases detected by Ga-68 PSMA PET/CT but not by conventional imaging. Graphic courtesy of the Department of Nuclear Medicine, Royal North Shore Hospital, Sydney
News | Prostate Cancer | June 15, 2017
An estimated one in seven American men will be affected by...
IMAGE OF THE YEAR: Dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer. Technology of dual-labeled PSMA-inhibitors for PET/CT imaging and fluorescence-guided intraoperative identification of metastases. This work might help to establish a new treatment regimen for more precise and sensitive pre-, intra- and post-therapeutic detection of prostate cancer.
Credit: Courtesy of A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center, Heidelberg, Germany; T. Simpfendörfer, B. Hadaschik, U. Haberkorn, Heidelberg University Hospital, Heidelberg, Germany; PET-image: Afshar-Oromieh et al., EJNMMI 2013; 40(4); STED-image: J. Matthias, German Cancer Research Center.
This study was supported by the VIP+ fund, Federal Ministry of Education & Research (BMBF), Germany.
Scientific Paper 531: “Preclinical evaluation of dual-labeled PSMA-inhibitors for the diagnosis and therapy of prostate cancer.” A. Baranski, M. Schäfer, U. Bauder-Wüst, M. Roscher, J. Schmidt, E. Stenau, L. Maier-Hein, M. Eder, K. Kopka, German Cancer Research Center (DKFZ), Heidelberg, Germany; T. Simpfendörfer, B. Hadaschik, U. Haberkorn, University Hospital, Heidelberg, Germany. Presented at SNMMI’s 64th Annual Meeting, June 10-14, 2017, Denver, Colo.
News | Prostate Cancer | June 15, 2017
In the battle against metastatic ...
Axial fused 89Zr-5B1 antibody PET/CT image demonstrates focus of uptake in the liver (arrow). Focus of uptake correlates with increased liver metastasis seen on diagnostic CT (red arrow) performed 2 weeks prior. Image courtesy of Christian Lohrmann, Jason Lewis, Wolfgang Weber, Memorial Sloan Kettering Cancer Center; MabVax Therapeutics
News | PET-CT | June 14, 2017
Pancreatic cancer is associated with bleak five-year survival rates and limited treatment options, but new research...
While subject No. 1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in subject No. 2 (right). Image courtesy of Henryk Barthel et al., University Hospital Leipzig, Leipzig, Germany
News | PET Imaging | June 14, 2017
More people die of Alzheimer's disease than prostate and breast cancer combined. Identifying the disease before...
News | Pediatric Imaging | June 14, 2017
Despite evidence showing that the routine use of sonography...
